Rossi, G A <br/><br/>
Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Clinical response is not associated with evidence of enhancement of local cellular-mediated immunity.  [electronic resource] 

 -  The American review of respiratory disease  Apr 1987 
 - 885-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-0805 
<br/><br/><label>Standard No.: </label>10.1164/arrd.1987.135.4.885  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Bacterial Vaccines<br/>Corynebacterium<br/>Female<br/>Humans<br/>Immunity, Cellular<br/>Immunotherapy<br/>Interferons--analysis<br/>Killer Cells, Natural--immunology<br/>Lung Neoplasms--complications<br/>Male<br/>Middle Aged<br/>Monocytes--immunology<br/>Pleura--immunology<br/>Pleural Effusion--etiology<br/>Propionibacterium acnes<br/>Recurrence<br/>T-Lymphocytes--classification